This article details the shareholder structure of Fenbo Holdings Ltd (FEBO), listing its major shareholders and their respective proportions. Key institutional holdings are highlighted, including Susquehanna International Group, LLP, XTX Markets LLC, and HRT Financial LP, along with a historical overview of institutional shareholding changes over several quarters. The report also provides updates on shareholder activity and changes in their positions.

This article provides an overview of the institutional confidence in Origin Agritech Ltd (SEED), detailing changes in shareholdings by various entities. It lists top institutional shareholders and their recent adjustments in share ownership, indicating their investment activity in the company. The data highlights significant percentage changes in holdings for some investors.

Xue Bing, EVP of Worldwide Sales & Business Development at Alpha & Omega Semiconductor (NASDAQ:AOSL), sold 4,916 common shares for $231,494 under a pre-arranged trading plan. Following the transaction, Mr. Bing directly holds 123,660 common shares, including various unvested equity awards. This sale comes amidst the company's recent fiscal Q3 2026 earnings, which showed a revenue beat but an EPS miss, alongside the introduction of new digital multiphase controllers.

This article provides a valuation analysis for DT Cloud Acquisition Corp (DYCQR). It notes that relevant data for P/E, P/B, P/S, and P/CF ratios have not been disclosed by the company yet, indicating that a comprehensive valuation is currently unavailable. The article includes the stock's market capitalization and current trading price.

Silence Therapeutics PLC (SLN) has an earnings forecast score of 8.00, ranking 163rd in the Biotechnology & Medical Research industry. Analysts have set an average price target of $30.00, with a high of $75.00 and a low of $4.00. Based on ratings from 6 analysts, most recommend a "Buy" for the stock.

This article provides details on the institutional confidence in Silexion Therapeutics Corp (SLXNW), listing the shares held by various institutional investors and indicating changes in their holdings. Key institutional shareholders include Polar Asset Management Partners Inc., Linden Advisors L.P., and Aristeia Capital, L.L.C., with notable changes like Clear Street LLC increasing its holdings by over 51%. The overall institutional confidence score is noted as 0.00, suggesting either no current score or a negligible impact.

Gilead is celebrating one year since the U.S. FDA approved its twice-yearly HIV prevention medication, a result of nearly 20 years of research and the screening of 4,000 molecules. The company has made efforts to ensure broad global access, including voluntary royalty-free licensing agreements with generic manufacturers and commitments to supply millions of doses at no profit to low-income countries. Additionally, the innovative therapy has received regulatory approvals in several other countries, particularly in regions with high need, within the year of its U.S. launch.

Coinbase director Tobias Lütke reported routine equity compensation activity, with 1,100 restricted stock units (RSUs) vesting into Class A Common Stock. This transaction increased his direct holdings to 14,585 shares. Additionally, Lütke received a new grant of 2,215 RSUs, which will vest on the earlier of June 16, 2027, or the next annual shareholder meeting, reinforcing his continued service to the company.

Coinbase director Chris Lehane reported the vesting of 1,100 restricted stock units (RSUs) into Class A Common Stock, bringing his direct holdings to 3,028 shares. Concurrently, he received a new grant of 2,215 RSUs, which are set to vest on the earlier of June 18, 2026, or the next annual shareholder meeting, contingent on his continued service. This activity is characterized as routine equity compensation rather than open-market transactions.

Ralph Lauren (NYSE: RL) is holding its 2026 Annual Meeting of Stockholders virtually on July 30, 2026, where shareholders will vote on the election of 12 directors, ratification of its independent auditor Ernst & Young LLP, and an advisory vote on executive compensation. The company highlighted strong financial performance in Fiscal 2026, including growth in total revenue and adjusted operating income, and its continued focus on the "Next Great Chapter: Drive" strategy. Discussions also covered the company's dual-class share structure, which the Nominating Committee again recommended retaining due to perceived long-term stability benefits and the significant economic interest of the Lauren family.